COLL - Collegium Pharmaceutical Inc
IEX Last Trade
38.47
-0.140 -0.364%
Share volume: 199,130
Last Updated: Fri 30 Aug 2024 09:59:43 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$38.61
-0.14
-0.36%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-07 | 2024-02-22 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 1.246 B | 1.201 B | 1.174 B | 1.214 B | 1.214 B | 1.178 B | 1.143 B | 1.114 B | |
| Current Assets | 409.774 M | 405.216 M | 419.989 M | 498.300 M | 537.297 M | 537.086 M | 537.600 M | 539.260 M | |
| Inventories | 77.769 M | 64.652 M | 46.501 M | 32.895 M | 26.026 M | 34.125 M | 32.332 M | 31.276 M | |
| Other Current Assets | 11.778 M | 11.036 M | 16.681 M | 16.798 M | 18.322 M | 16.545 M | 15.195 M | 15.243 M | |
| Short Term Investments | 11.778 M | 11.036 M | 16.681 M | 16.798 M | 18.322 M | 16.545 M | 15.195 M | 15.243 M | |
| Total Receivables | 197.505 M | 195.402 M | 183.119 M | 179.127 M | 167.479 M | 181.851 M | 179.525 M | 174.693 M | |
| Current Cash | 122.722 M | 134.126 M | 173.688 M | 269.480 M | 325.470 M | 304.565 M | 310.548 M | 318.048 M | |
| Total Non-current Assets | 835.800 M | 795.724 M | 754.142 M | 715.999 M | 676.615 M | 640.492 M | 605.708 M | 574.990 M | |
| Property Plant Equipment | 19.965 M | 19.744 M | 19.521 M | 18.879 M | 18.040 M | 16.645 M | 15.983 M | 15.457 M | |
| Other Assets | 67.000 K | 57.000 K | 100.000 K | 87.000 K | 74.000 K | 740.000 K | 825.000 K | 954.000 K | |
| Intangible Assets | 647.299 M | 609.747 M | 567.468 M | 530.002 M | 492.539 M | 456.222 M | 421.708 M | 387.191 M | |
| Goodwill | 130.094 M | 130.094 M | 133.695 M | 133.857 M | 133.857 M | 133.857 M | 133.857 M | 133.857 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.246 B | 1.201 B | 1.174 B | 1.214 B | 1.214 B | 1.178 B | 1.143 B | 1.114 B | |
| Total liabilities | 1.048 B | 1.004 B | 979.289 M | 1.035 B | 1.013 B | 998.705 M | 947.877 M | 892.081 M | |
| Total current liabilities | 415.094 M | 414.497 M | 433.726 M | 412.702 M | 435.058 M | 464.612 M | 457.915 M | 446.436 M | |
| Accounts Payable | 6.627 M | 7.637 M | 3.494 M | 2.992 M | 2.420 M | 3.653 M | 8.692 M | 6.020 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 120.833 M | 141.667 M | 162.500 M | 183.333 M | 183.333 M | 183.333 M | 183.333 M | 183.333 M | |
| Long term debt | 625.268 M | 581.902 M | 538.451 M | 614.991 M | 571.419 M | 527.709 M | 483.838 M | 439.785 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 197.612 M | 197.194 M | 194.842 M | 179.733 M | 200.805 M | 178.873 M | 195.431 M | 222.169 M | |
| Common stock | 34.002 M | 34.059 M | 33.584 M | 34.319 M | 34.622 M | 33.744 M | 32.279 M | 32.327 M | |
| Retained earnings | -274.602 M | -274.145 M | -281.344 M | -298.770 M | -285.763 M | -265.129 M | -233.189 M | -205.476 M |